{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T03:13:00Z","timestamp":1794107580327,"version":"4.8.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T00:00:00Z","timestamp":1766707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T00:00:00Z","timestamp":1769472000000},"content-version":"vor","delay-in-days":32,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-33537-y","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T17:34:31Z","timestamp":1766770471000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["HIV case management using agent-based modeling approach subject to antiretroviral therapy and lifestyle treatment plan"],"prefix":"10.1038","volume":"16","author":[{"given":"Akintayo Emmanuel","family":"Akinsunmade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Azagbaekwue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friday Gabriel","family":"Emunefe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwaseun Biodun","family":"Onuoha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Raso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,26]]},"reference":[{"issue":"5255","key":"33537_CR1","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1126\/science.271.5255.1582","volume":"271","author":"AS Perelson","year":"1996","unstructured":"Perelson, A. S., Neumann, A. U., Markowitz, M., Leonard, J. M. & Ho, D. D. Hiv-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time. Science 271(5255), 1582\u20131586. https:\/\/doi.org\/10.1126\/science.271.5255.1582 (1996).","journal-title":"Science"},{"issue":"5","key":"33537_CR2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1089\/biores.2014.0024","volume":"3","author":"PS Rivadeneira","year":"2014","unstructured":"Rivadeneira, P. S. et al. Mathematical modeling of hiv dynamics after antiretroviral therapy initiation: A review. Biores. Open Access 3(5), 233\u2013241. https:\/\/doi.org\/10.1089\/biores.2014.0024 (2014).","journal-title":"Biores. Open Access"},{"issue":"6629","key":"33537_CR3","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/387188a0","volume":"387","author":"AS Perelson","year":"1997","unstructured":"Perelson, A. S. et al. Decay characteristics of hiv-1-infected compartments during combination therapy. Nature 387(6629), 188\u2013191. https:\/\/doi.org\/10.1038\/387188a0 (1997).","journal-title":"Nature"},{"issue":"1","key":"33537_CR4","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1038\/s41540-025-00538-6","volume":"11","author":"G Rasi","year":"2025","unstructured":"Rasi, G., Emili, E., Conway, J. M., Cotugno, N. & Palma, P. Mathematical modeling and mechanisms of hiv latency for personalized anti latency therapies. NPJ Syst. Biol. Appl. 11(1), 64. https:\/\/doi.org\/10.1038\/s41540-025-00538-6 (2025).","journal-title":"NPJ Syst. Biol. Appl."},{"key":"33537_CR5","doi-asserted-by":"publisher","first-page":"1541942","DOI":"10.3389\/fmicb.2025.1541942","volume":"16","author":"R Jin","year":"2025","unstructured":"Jin, R. & Zhang, L. Ai applications in hiv research: advances and future directions. Front. Microbiol. 16, 1541942. https:\/\/doi.org\/10.3389\/fmicb.2025.1541942 (2025).","journal-title":"Front. Microbiol."},{"issue":"4","key":"33537_CR6","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1124\/pharmrev.122.000810","volume":"75","author":"W Sadee","year":"2023","unstructured":"Sadee, W., Wang, D., Hartmann, K. & Toland, A. E. Pharmacogenomics: Driving personalized medicine. Pharmacol. Rev. 75(4), 789\u2013814. https:\/\/doi.org\/10.1124\/pharmrev.122.000810 (2023).","journal-title":"Pharmacol. Rev."},{"issue":"9","key":"33537_CR7","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1038\/nm.2892","volume":"18","author":"DI Rosenbloom","year":"2012","unstructured":"Rosenbloom, D. I., Hill, A. L., Rabi, S. A., Siliciano, R. F. & Nowak, M. A. Antiretroviral dynamics determines hiv evolution and predicts therapy outcome. Nat. Med. 18(9), 1378\u20131385. https:\/\/doi.org\/10.1038\/nm.2892 (2012).","journal-title":"Nat. Med."},{"issue":"6","key":"33537_CR8","doi-asserted-by":"publisher","first-page":"2027","DOI":"10.1007\/s11538-007-9203-3","volume":"69","author":"L Rong","year":"2007","unstructured":"Rong, L., Feng, Z. & Perelson, A. S. Emergence of hiv-1 drug resistance during antiretroviral treatment. Bull. Math. Biol. 69(6), 2027\u20132060. https:\/\/doi.org\/10.1007\/s11538-007-9203-3 (2007).","journal-title":"Bull. Math. Biol."},{"issue":"1","key":"33537_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1006\/bulm.2001.0266","volume":"64","author":"DS Callaway","year":"2002","unstructured":"Callaway, D. S. & Perelson, A. S. Hiv-1 infection and low steady state viral loads. Bull. Math. Biol. 64(1), 29\u201364. https:\/\/doi.org\/10.1006\/bulm.2001.0266 (2002).","journal-title":"Bull. Math. Biol."},{"issue":"2","key":"33537_CR10","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.jtbi.2009.06.011","volume":"260","author":"L Rong","year":"2009","unstructured":"Rong, L. & Perelson, A. S. Modeling hiv persistence, the latent reservoir, and viral blips. J. Theor. Biol. 260(2), 308\u2013331. https:\/\/doi.org\/10.1016\/j.jtbi.2009.06.011 (2009).","journal-title":"J. Theor. Biol."},{"issue":"5197","key":"33537_CR11","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1126\/science.7824947","volume":"267","author":"JM Coffin","year":"1995","unstructured":"Coffin, J. M. Hiv population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science 267(5197), 483\u2013489. https:\/\/doi.org\/10.1126\/science.7824947 (1995).","journal-title":"Science"},{"issue":"3","key":"33537_CR12","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1517\/17425255.2.3.459","volume":"2","author":"PA Pham","year":"2006","unstructured":"Pham, P. A. & Gallant, J. E. Tenofovir disoproxil fumarate for the treatment of hiv infection. Expert Opin. Drug Metab. Toxicol. 2(3), 459\u2013469. https:\/\/doi.org\/10.1517\/17425255.2.3.459 (2006).","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"issue":"13","key":"33537_CR13","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1097\/00002030-200309050-00005","volume":"17","author":"EW Fiebig","year":"2003","unstructured":"Fiebig, E. W. et al. Dynamics of hiv viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary hiv infection. AIDS 17(13), 1871\u20131879. https:\/\/doi.org\/10.1097\/00002030-200309050-00005 (2003).","journal-title":"AIDS"},{"issue":"6418","key":"33537_CR14","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/362355a0","volume":"362","author":"G Pantaleo","year":"1993","unstructured":"Pantaleo, G. et al. Hiv infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 362(6418), 355\u2013358. https:\/\/doi.org\/10.1038\/362355a0 (1993).","journal-title":"Nature"},{"issue":"1","key":"33537_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.cam.2005.02.004","volume":"184","author":"BM Adams","year":"2007","unstructured":"Adams, B. M. et al. Hiv dynamics: Modeling data analysis, and optimal treatment protocols. J. Comput. Appl. Math. 184(1), 10\u201349. https:\/\/doi.org\/10.1016\/j.cam.2005.02.004 (2007).","journal-title":"J. Comput. Appl. Math."},{"issue":"14","key":"33537_CR16","doi-asserted-by":"publisher","first-page":"7681","DOI":"10.1073\/pnas.97.14.7681","volume":"97","author":"RM Ribeiro","year":"2008","unstructured":"Ribeiro, R. M. & Bonhoeffer, S. Production of resistant hiv mutants during antiretroviral therapy. Proc. Natl. Acad. Sci. 97(14), 7681\u20137686. https:\/\/doi.org\/10.1073\/pnas.97.14.7681 (2008).","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"27","key":"33537_CR17","doi-asserted-by":"publisher","first-page":"9714","DOI":"10.1073\/pnas.0501870102","volume":"102","author":"NL Komarova","year":"2009","unstructured":"Komarova, N. L. & Wodarz, D. Drug resistance in cancer: principles of emergence and prevention. Proc. Natl. Acad. Sci. 102(27), 9714\u20139719. https:\/\/doi.org\/10.1073\/pnas.0501870102 (2009).","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"7","key":"33537_CR18","doi-asserted-by":"publisher","first-page":"272","DOI":"10.3390\/technologies13070272","volume":"13","author":"X Zhang","year":"2025","unstructured":"Zhang, X. et al. Agent-based modeling of epidemics: Approaches, applications, and future directions. Technologies 13(7), 272. https:\/\/doi.org\/10.3390\/technologies13070272 (2025).","journal-title":"Technologies"},{"issue":"7","key":"33537_CR19","doi-asserted-by":"publisher","first-page":"104543","DOI":"10.1016\/j.jbi.2023.104543","volume":"148","author":"R Sun","year":"2023","unstructured":"Sun, R. & Bai, Z. The application of simulation methods during the covid-19 pandemic: A scoping review. J. Biomed. Inform. 148(7), 104543. https:\/\/doi.org\/10.1016\/j.jbi.2023.104543 (2023).","journal-title":"J. Biomed. Inform."},{"key":"33537_CR20","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1186\/1471-2458-14-1019","volume":"14","author":"S Lukens","year":"2014","unstructured":"Lukens, S. et al. A large-scale immuno-epidemiological simulation of influenza a epidemics. BMC Public Health 14, 1019. https:\/\/doi.org\/10.1186\/1471-2458-14-1019 (2014).","journal-title":"BMC Public Health"},{"key":"33537_CR21","doi-asserted-by":"publisher","first-page":"104364","DOI":"10.1016\/j.jbi.2023.104364","volume":"141","author":"D De-Leon","year":"2023","unstructured":"De-Leon, D. & Aran, H. Mam: Flexible monte-carlo agent based model for modelling covid-19 spread. J. Biomed. Inform. 141, 104364. https:\/\/doi.org\/10.1016\/j.jbi.2023.104364 (2023).","journal-title":"J. Biomed. Inform."},{"key":"33537_CR22","doi-asserted-by":"publisher","first-page":"e1009146","DOI":"10.1371\/journal.pcbi.1009146","volume":"17","author":"W Hinch","year":"2021","unstructured":"Hinch, W. et al. Openabm-covid19\u2014an agent-based model for non-pharmaceutical interventions against covid-19 including contact tracing. PLoS Comput. Biol. 17, e1009146. https:\/\/doi.org\/10.1371\/journal.pcbi.1009146 (2021).","journal-title":"PLoS Comput. Biol."},{"key":"33537_CR23","doi-asserted-by":"publisher","first-page":"104315","DOI":"10.1016\/j.autcon.2022.104315","volume":"140","author":"N Seresht","year":"2022","unstructured":"Seresht, N. Enhancing resilience in construction against infectious diseases using stochastic multi-agent approach. Autom. Constr. 140, 104315. https:\/\/doi.org\/10.1016\/j.autcon.2022.104315 (2022).","journal-title":"Autom. Constr."},{"issue":"14","key":"33537_CR24","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1097\/QAD.0000000000002681","volume":"34","author":"S Jenness","year":"2022","unstructured":"Jenness, S., Johnson, J., Hoover, K., Smith, D. & Delaney, K. Modeling an integrated hiv prevention and care continuum to achieve the ending the hiv epidemic goals. AIDS 34(14), 2103\u20132113. https:\/\/doi.org\/10.1097\/QAD.0000000000002681 (2022).","journal-title":"AIDS"},{"issue":"7","key":"33537_CR25","doi-asserted-by":"publisher","first-page":"e491","DOI":"10.1016\/S2352-3018(20)30033-3","volume":"7","author":"B Nosyk","year":"2020","unstructured":"Nosyk, B. et al. Ending the hiv epidemic in the USA: an economic modelling study in six cities. The Lancet HIV 7(7), e491\u2013e503. https:\/\/doi.org\/10.1016\/S2352-3018(20)30033-3 (2020).","journal-title":"The Lancet HIV"},{"issue":"10","key":"33537_CR26","doi-asserted-by":"publisher","first-page":"e0274288","DOI":"10.1371\/journal.pone.0274288","volume":"17","author":"W Vermeer","year":"2022","unstructured":"Vermeer, W. et al. Agent-based model projections for reducing hiv infection among msm: Prevention and care pathways to end the hiv epidemic in chicago, illinois. PLoS ONE 17(10), e0274288. https:\/\/doi.org\/10.1371\/journal.pone.0274288 (2022).","journal-title":"PLoS ONE"},{"issue":"3","key":"33537_CR27","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1097\/QAD.0b013e32835ca2dd","volume":"27","author":"I Cremin","year":"2013","unstructured":"Cremin, I. et al. The new role of antiretrovirals in combination hiv prevention: a mathematical modelling analysis. AIDS 27(3), 447\u2013458. https:\/\/doi.org\/10.1097\/QAD.0b013e32835ca2dd (2013).","journal-title":"AIDS"},{"issue":"9657","key":"33537_CR28","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/S0140-6736(08)61697-9","volume":"373","author":"RM Granich","year":"2009","unstructured":"Granich, R. M., Gilks, C. F., Dye, C., De Cock, K. M. & Williams, B. G. Universal voluntary hiv testing with immediate antiretroviral therapy as a strategy for elimination of hiv transmission: a mathematical model. The Lancet 373(9657), 48\u201357. https:\/\/doi.org\/10.1016\/S0140-6736(08)61697-9 (2009).","journal-title":"The Lancet"},{"issue":"7","key":"33537_CR29","doi-asserted-by":"publisher","first-page":"e1001245","DOI":"10.1371\/journal.pmed.1001245","volume":"9","author":"JW Eaton","year":"2012","unstructured":"Eaton, J. W. et al. Hiv treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on hiv incidence in south africa. PLoS Med. 9(7), e1001245. https:\/\/doi.org\/10.1371\/journal.pmed.1001245 (2012).","journal-title":"PLoS Med."},{"issue":"8","key":"33537_CR30","doi-asserted-by":"publisher","first-page":"5087","DOI":"10.1128\/JVI.69.8.5087-5094.1995","volume":"69","author":"LM Mansky","year":"1995","unstructured":"Mansky, L. M. & Temin, H. M. Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase. J. Virol. 69(8), 5087\u20135094. https:\/\/doi.org\/10.1128\/JVI.69.8.5087-5094.1995 (1995).","journal-title":"J. Virol."},{"issue":"12","key":"33537_CR31","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/nm1295-1284","volume":"1","author":"TW Chun","year":"1995","unstructured":"Chun, T. W. et al. In vivo fate of hiv-1-infected t cells: quantitative analysis of the transition to stable latency. Nat. Med. 1(12), 1284\u20131290. https:\/\/doi.org\/10.1038\/nm1295-1284 (1995).","journal-title":"Nat. Med."},{"key":"33537_CR32","first-page":"1","volume":"63","author":"CDC","year":"2014","unstructured":"CDC. Revised surveillance case definition for hiv infection\u2014United States, 2014. Morb. Mortal. Wkly. Rep. 63, 1\u201310 (2014).","journal-title":"Morb. Mortal. Wkly. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33537-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33537-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33537-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T10:34:30Z","timestamp":1769510070000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-33537-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,26]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["33537"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-33537-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7642060\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,26]]},"assertion":[{"value":"17 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3605"}}